
MOTS-C 20mg (Mitochondrial-Derived Peptide)
Research Use Only
Note
Our peptide products are not intended to treat, prevent, mitigate or cure any disease or medical condition. Researchers must be at least eighteen (18) years of age to purchase. All products are sold strictly for in vitro laboratory research by qualified professionals.
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a mitochondrial-derived peptide studied for its role in metabolic homeostasis, exercise biology, and cellular aging research. This 20mg vial supports extended research protocols.
Related Research News
MOTS-c Guide: Mitochondrial Peptide for Canada Research
MOTS-c stands out as a 16-amino-acid peptide encoded by mitochondrial DNA, distinct from nuclear-gene peptides. Discovered in 2015, it influences metabolic regulation, AMPK signaling, and aging mechanisms. This guide details its features, verification steps, and research applications for Canadian buyers.
MOTS-c: The Mitochondrial Peptide for Metabolic Health
MOTS-c, a 16-amino-acid peptide encoded by mitochondrial DNA, regulates metabolism and responds to stress by signaling from mitochondria to the nucleus. Research shows it activates AMPK, declines with age, and mimics exercise effects in preclinical models. Studies link lower levels to type 2 diabetes and age-related physical decline.
Anti-Aging Peptides: Research Compounds for Metabolism, Muscle, and Tissue Health
Explore a curated selection of anti-aging research peptides including BPC-157, GHK-CU, KPV, MOTS-C, NAD+, Retatrutide, SS-31, TB-500, and others. These compounds are studied for their potential roles in metabolism support, muscle growth, weight loss, and skin, tissue, and bone health. Average purity across products is 99.77%.
Explore Research
Peptide Tools
Frequently Bought Together

MOTS-C 20mg
20mg
$54 USD
Bundle & Save
$89 USD
Save $4 USD
$119 USD
Save $14 USD
$214 USD
Save $34 USD
$249 USD
Save $49 USD
Click any product above to toggle selection
Someone in Tampa, FL purchased
GHK-Cu 50mg
18 minutes ago



